- Researchers compared corneal epitheliotrophic factors in APRP and AS eye drops for treating dry eye disease.
- They observed significant differences in growth factor concentrations between APRP and AS. 3
- APRP was preferable for early-stage ocular surface disorders and mucin-deficient dry eye, while AS was recommended for persistent epithelial defects.
- The researchers concluded that tailored treatments could target growth factor supply.
Source: Ophthalmology and Therapy
